
HOOKIPA Pharma HOOK
Quarterly report 2025-Q1
added 05-15-2025
HOOKIPA Pharma EV - Enterprise Value 2011-2026 | HOOK
Annual EV - Enterprise Value HOOKIPA Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.5 M | 9.82 M | 46 M | 177 M | 139 M | -24.7 M | 55 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 177 M | -24.7 M | 60.5 M |
EV - Enterprise Value of other stocks in the Biotechnology industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
ACADIA Pharmaceuticals
ACAD
|
3.33 B | $ 22.5 | 1.86 % | $ 3.73 B | ||
|
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M | ||
|
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
125 M | - | - | $ 86.2 M | ||
|
AlloVir
ALVR
|
-55.1 M | - | 4.14 % | $ 49.1 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
43.3 B | $ 327.16 | 2.39 % | $ 42.9 B | ||
|
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | ||
|
Amgen
AMGN
|
189 B | $ 349.22 | 2.71 % | $ 188 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.92 B | $ 20.4 | -0.87 % | $ 954 M | ||
|
Applied Therapeutics
APLT
|
563 M | - | - | $ 8.42 M | ||
|
I-Mab
IMAB
|
8.28 B | - | - | $ 866 M | ||
|
Aquestive Therapeutics
AQST
|
540 M | $ 4.18 | 1.33 % | $ 447 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
168 B | - | 2.54 % | $ 160 B | ||
|
Arcutis Biotherapeutics
ARQT
|
3.64 B | $ 24.57 | 5.59 % | $ 3.13 B | ||
|
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M | ||
|
AVROBIO
AVRO
|
-35.4 M | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
59.6 B | - | - | $ 96.9 B | ||
|
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | ||
|
Autolus Therapeutics plc
AUTL
|
629 M | $ 1.48 | 8.46 % | $ 394 M | ||
|
BeiGene, Ltd.
BGNE
|
-720 M | - | 0.49 % | $ 251 B | ||
|
Alterity Therapeutics Limited
ATHE
|
-28.9 M | $ 3.85 | 2.41 % | $ 9.26 B | ||
|
BioNTech SE
BNTX
|
-4.91 B | $ 91.76 | 2.39 % | $ 27.2 B | ||
|
CymaBay Therapeutics
CBAY
|
3.36 B | - | - | $ 3.45 B | ||
|
Advaxis
ADXS
|
-3.02 M | - | -9.65 % | $ 45.9 M | ||
|
Aytu BioScience
AYTU
|
-15.2 M | $ 2.71 | 5.51 % | $ 17 M | ||
|
Avid Bioservices
CDMO
|
661 M | - | - | $ 789 M | ||
|
Cidara Therapeutics
CDTX
|
9.99 M | - | - | $ 1.41 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
647 M | $ 3.06 | 0.99 % | $ 6.66 B | ||
|
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - | ||
|
Cabaletta Bio
CABA
|
253 M | $ 3.06 | -0.33 % | $ 307 M | ||
|
Checkpoint Therapeutics
CKPT
|
174 M | - | - | $ 169 M | ||
|
Cerus Corporation
CERS
|
632 M | $ 1.9 | 2.99 % | $ 362 M | ||
|
Coherus BioSciences
CHRS
|
335 M | $ 1.7 | 1.8 % | $ 199 M | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
169 M | $ 0.36 | 0.28 % | $ 4.12 M | ||
|
Aeterna Zentaris
AEZS
|
5.52 M | - | 5.93 % | $ 314 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
11.4 M | - | - | $ 231 M | ||
|
AgeX Therapeutics
AGE
|
3.93 M | - | -10.17 % | $ 12.2 K | ||
|
Concert Pharmaceuticals
CNCE
|
14.7 M | - | - | $ 401 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-23.2 M | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-9.16 M | - | - | $ 26.5 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
2.48 B | $ 25.57 | 2.3 % | $ 3.13 B | ||
|
CTI BioPharma Corp.
CTIC
|
664 M | - | - | $ 1.2 B | ||
|
AIkido Pharma
AIKI
|
9.53 M | - | 1.93 % | $ 17.4 M | ||
|
Aptose Biosciences
APTO
|
36.2 M | - | -45.71 % | $ 1.2 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-2.16 M | - | -4.36 % | $ 27 M | ||
|
Cellectar Biosciences
CLRB
|
-651 K | $ 2.81 | 2.18 % | $ 7.33 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
1.24 B | - | - | $ 2.18 B |